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Background: Adnexal tumours are frequently diagnosed in asymptomatic postmenopausal women due to more liberal use of
modern high-resolution imaging. This study’s objective was to determine if there would be a difference in the intervention rates
when using the Simple Rules Management Protocol (SRMP) as compared to the Risk of Malignancy Index in the Royal College of
Obstetricians and Gynaecologists guideline (RMI/RCOG).
Methods: This was a prospective randomised controlled trial with the participants and the researchers non-blinded, and
the surgeons and pathologists blinded. We recruited pain-free postmenopausal women who were diagnosed with an
adnexal tumour on ultrasound scan. Women were randomised to either of the two protocols, which then determined if they
were offered conservative or surgical management. An intention-to-treat analysis was performed. The primary outcome
measure was rate of surgical interventions for ovarian cysts up to 12 months after randomisation. The secondary outcome
measures were the number of staging surgical procedures, surgical complications and number of delayed diagnoses of ovarian
cancer.
Results: A total of 148 women were randomised over 39 months with 73 in the RMI/RCOG arm and 75 in the SRMP arm with
outcome data for 136 at 12 months. The two groups were balanced in terms of age, length of time since menopause and use of
hormone replacement therapy. There were 18 out of 68 (28.1%) women in the RMI/RCOG arm who had surgery vs 7 out of 68
(10.3%) women in the SRMP arm (P¼ 0.015, w2-test). The difference in these proportions was 16.2% (95% confidence interval (CI):
3.4–28.9%) and the relative risk was 2.57 (95% CI: 1.15–5.76). There were no significant differences in the number of staging surgical
procedures and the surgical complications between the two groups and there were no delayed diagnoses of ovarian cancer at 12
months.
Conclusions: Surgical intervention rates in asymptomatic postmenopausal women with an ultrasound diagnosis of adnexal
tumours are significantly lower when the novel SRMP protocol is used for triaging compared to the standard RMI/RCOG protocol
without an increase in delayed malignant diagnoses.
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In recent years, there has been an increase in the number of
women diagnosed with asymptomatic adnexal tumours. This is
mainly due to liberal use of modern high-resolution abdominal and
pelvic imaging such as ultrasound, MRI and CT. The diagnosis of
an adnexal tumour often causes concern to women and health
professionals due to perceived difficulties in distinguishing between
benign and malignant ovarian tumours.
The best survival rates for patients with ovarian cancer are
achieved when treatment is organised and carried out by
gynaecological oncologists who work in cancer centres
(Vernooij et al, 2007). However, women with asymptomatic
benign tumours can be managed expectantly or by minimally
invasive surgery. These procedures can be safely undertaken by
general gynaecologists in their local hospitals. Achieving the right
balance between the desire to treat all ovarian cancers effectively
and without delay against the need to avoid unnecessary
interventions in women with benign and clinically insignificant
lesions is particularly important in postmenopausal women. They
are more likely to have age–related, co-morbid conditions such as
cardiac or pulmonary disease or diabetes mellitus that increase
their risk of surgical and anaesthetic complications. They are also
more likely to have had previous abdominal operations increasing
further their risk of surgical complications (Ben-Ami et al, 2006;
Ansaloni et al, 2010; Neufeld et al, 2013; Sztark et al, 2013; Krause
et al, 2016).
In 2003 the Royal College of Obstetricians and Gynaecologists
(RCOG) published a guideline on the management of ovarian cysts
in postmenopausal women, which was reviewed with no changes in
2010 (RCOG, 2003). The guideline uses the Risk of Malignancy
(RMI; Jacobs et al, 1990) model-based management protocol
(RMI/RCOG) to facilitate triaging of women with adnexal tumours
for surgery and it provides guidance as to whether the operation
should be carried in a specialised cancer centre or by a
general gynaecologist. In 2008 the International Ovarian Tumor
Analysis collaboration developed a novel ultrasound-based diag-
nostic model ‘Simple Rules’ (SR) for the differential diagnosis
between benign and malignant adnexal tumours (Timmerman
et al, 2008). This SR model has been incorporated into the RCOG
Green Top guideline for the management of ovarian cysts in
premenopausal women (RCOG, 2011). Reviews of published
literature showed that the SR model may be more sensitive than
RMI for the diagnosis of ovarian cancer (Geomini et al, 2009;
Kaijser et al, 2014; Nunes et al, 2014). The SR model defines
tumours as benign, indeterminate and malignant. Using the SR
diagnostic model we developed a new protocol for the manage-
ment of postmenopausal women diagnosed with adnexal cysts.
This new ‘Simple rules management protocol’ (SRMP) uses similar
approach to the standard RMI/RCOG protocol and classifies
adnexal lesions as low, intermediate and high risk of malignancy.
The literature has found indeterminate tumours to have an
intermediate risk of 18–45% of being malignant. This was used to
compare with the RMI/RCOG protocol, which had an intermediate
risk of malignancy of 20% (RCOG, 2003; Timmerman et al, 2008;
Nunes et al, 2014).
In our previous pilot study on a sample of 67 women we
found that 41 out of 67 (61.2%; 95% confidence interval (CI):
48.5–72.9%) women would be offered surgery according to the
RMI/RCOG protocol compared to 5 out of 67 (7.5%: 95% CI:
2.5–16.6%) when SRMP was used for triage (Nunes et al, 2012).
The aim of this prospective randomised trial was to determine
whether there are significant differences in the actual surgical
intervention rates between the two management protocols for
the management of postmenopausal women with incidentally
detected adnexal tumours. Secondary outcomes were the number
of staging surgical procedures, surgical complications and
number of delayed diagnoses of ovarian cancer in the two
groups.
MATERIALS AND METHODS
This was a prospective non-blinded single-centre randomised
controlled trial conducted in an outpatient gynaecology clinic at
University College Hospital, London, UK. Asymptomatic post-
menopausal women who were diagnosed with adnexal tumours on
ultrasound scan or other imaging modalities were invited to join
the study.
The North London Research Ethical Committee 2 as well as the
research and development committee at UCH approved the
randomised controlled trial (10/H0724/48).
Study participants. Eligible women were identified when they
attended the general gynaecology clinic, were postmenopausal and
were found to have an adnexal tumour and no recent history of
pelvic pain. An information leaflet about the study was given to all
eligible women before assessment. They were then reviewed by a
member of the research team who took a detailed clinical history,
did a physical examination and performed an ultrasound scan. If
the diagnosis of an adnexal mass was confirmed women were
invited to join the study. Written informed consent was obtained
from all women who agreed to take part.
Women were considered to be asymptomatic if they did not
present with pain localised to the area of the cyst or the lower
pelvis. Postmenopausal women were defined as those who had had
1 year of spontaneous amenorrhoea at or above the age of 40 where
no illness or medication had caused the cessation of periods, or
those at or above the age of 50 who had had a hysterectomy with
ovarian conservation. Women aged 40–80 inclusive were eligible.
We excluded all women who were unable or unwilling to give
written consent and those with simple, unilateral, unilocular cysts
of o2 cm. Women referred for an ultrasound scan from the
tertiary oncology unit were excluded as majority of them had
already had an RMI done and were usually aware of their results.
In addition, they had already been informed that they were likely to
have an ovarian cancer, which would require surgical or other
treatment.
Severe pelvic adhesions were determined by the women’s
history (multiple laparotomies, frozen pelvis at previous operation)
and examination (immobility of the cyst, frozen pelvis on
ultrasound scan and/or presence of a peritoneal pseudo-cyst).
Women who had already been booked for urogynaecological or
general gynaecological surgery were also excluded.
Randomisation and blinding. A blocked randomisation list with
varying block sizes was generated by an independent statistician
using Stata 12.1 (Stata Corp., College Station, TX, USA). The
randomisation numbers were placed in consecutively numbered,
sealed, opaque envelopes and kept in a box locked in a filing
cabinet. This randomisation ensured allocation concealment.
When a patient consented, a clinic nurse, who was not part of
the research team, opened the next envelope and informed the
recruiting doctor of woman’s trial allocation.
Neither the patient nor the recruiting doctors were blinded to
the protocol allocation but the operating surgeons and the
pathologists were. The surgeons were informed whether the
tumour was of high or intermediate risk of cancer, but not about
the protocol, which was used to determine that. The pathologist
was informed of the operative findings only and their report was
used to determine the nature of adnexal tumours.
Procedures. The women were randomised into either of the two
groups. The first group was assessed and managed in accordance
with the current RMI/RCOG protocol for the management of cysts
in postmenopausal women (RCOG, 2003). The second group of
women were assessed using a structured approach to morpholo-
gical analysis of ovarian tumours referred to as SRMP, which
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enables discrimination between benign and malignant lesions
without the need to measure tumour markers. According to the
literature the SR is more sensitive for the preoperative diagnosis of
ovarian cancer (Kaijser et al, 2014).
In the RMI/RCOG arm all the women underwent an ultrasound
examination and had a CA125 blood test on the same day. The
RMI was calculated as the product of the CA125 (Uml-1)
laboratory value, a score for menopausal status (1 if premenopausal
and 3 if postmenopausal) and a greyscale ultrasound score of 0, 1
or 3. Ultrasound features were bilaterality, ascites, multilocularity,
solid areas and intra-abdominal metastases, and where none were
present the score was 0, where 1 was present the score was 1 and
where 2–5 were present the score was 3. (RMI¼CA125MU;
Jacobs et al, 1990).
Women with all of the following features were classified as low
risk of cancer and were offered conservative management:
simple, regular, unilateral, unilocular cystso5 cm, a CA125o30
Uml-1 and an RMIo25. A simple cyst was defined as a
unilocular, anechoic, regular (smooth walls) cyst (Conway,
1998). Those with a RMI of 25–250 were considered to be at
intermediate risk and were offered surgical removal by
gynaecologists. Those with a RMIo25 but with a cyst which is
not simple, unilateral, unilocular and o5 cm were also
considered of indeterminate risk. Women with an RMI4250
were referred for surgery to the tertiary cancer centre as they
were considered high risk (Figure 1).
The second trial arm used SRMP. Women in this arm had an
ultrasound scan assessment according to the Simple Rules
Protocol. The ‘SR’ uses 10 features to assess adnexal masses. There
are five features that predict malignancy (M-features): (1) irregular
solid tumour; (2) ascites; (3) at least four papillary structures;
(4) irregular multilocular-solid tumour with a largest diameter of at
least 100mm; and (5) very-high-colour content on colour Doppler
examination (score 4). There are five features to predict benignity
(B-features): (1) unilocular cyst; (2) presence of solid components
where the largest solid component has a largest diameter of
o7mm; (3) acoustic shadows; (4) smooth multilocular tumour
o100mm in largest diameter; and (5) no detectable blood flow on
Doppler examination (score 1). If one or more M-features apply in
the absence of a B-feature, the mass is classified as malignant. If
one or more B-features apply in the absence of an M-feature, the
mass is classified as benign. If no features apply or both M- and
B-features apply, the mass cannot be classified and is considered
indeterminate. In the SRMP the indeterminate tumours were
classified to be of intermediate risk.
All primary ultrasound scans were performed by NN using a
General Electric Voluson E8 ultrasound machine (GE Healthcare,
Milwaukee, WI, USA) with a 4–9MHz transvaginal probe or a
Wide Band Convex 2–8MHz transabdominal probe.
As previously described, women with a cyst classified as benign
using SRMP were considered low risk and they were offered
conservative management (Nunes et al, 2012). Those classified as
malignant were high risk and were managed by gynaecological
oncologists in the tertiary oncology unit. Women with tumours
of indeterminate nature were considered intermediate risk and
were offered surgery by general gynaecologists with interest in
cancer.
Women selected for conservative management were offered
three 4-monthly ultrasound scans for 12 months. Those within the
RMI/RCOG arm had another CA125 test at their final follow-up
visit. At follow-up visits women were asked about any change in
their symptoms. The tumours were assessed on ultrasound scan
looking for any changes in their morphology and size according to
the protocol of the trial arm to which they were randomised.
Women who began to experience pain or whose tumours were re-
classified as intermediate or high risk on follow-up ultrasound scan
were offered surgical treatment.
The decision about the surgical approach; that is, open vs
minimally invasive, was made by the operating surgeon.
Outcome measures
Primary outcome measure. The primary outcome was the
proportion of women who underwent surgery within 12 months
from randomisation.
Secondary outcomes. Secondary outcomes included the number of
staging surgical procedures carried out by a gynaecological
oncologist, which was defined as an operation performed by the
gynaecological oncology team where a systematic examination of the
pelvis and abdomen was performed looking for metastatic spread
with the appropriate biopsies done such as an omental biopsy or
lymph node dissection. Other secondary outcomes were the number
Study explained and women invited to participate
Written consent obtained.
Randomised RMI/RCOG or SRMP
Declined
management as per
unit protocol 
1. Women diagnosed with an adnexal tumour and have no pain
2. Inclusion criteria fulfilled and no exclusion criteria present
RMI/RCOG SRMP
Benign
RMI<25 and
Simple unilateral
cyst <5 cm and
CA125 <30   
No surgery
Follow up 4
monthly scans for
12 months  
Malignant
RMI >250
Oncology
Referral
Cancer
Centre   
Benign
‘Simple Rules’
assess as
benign
No surgery
Follow up 4
monthly scans
for 12 months   
Malignant
‘Simple Rules’
assess as
malignant
Oncology Referral
Cancer Centre 
Intermediate
‘Simple Rules’ do not
apply. 
Surgery required
general gynaecologist
/ cancer unit
Change to surgical group: cyst risk category changes / pain
develops.
Change to surgical group: cyst risk category changes / pain
develops.  
Intermediate
RMI<25 but cyst not
simple unilateral <5cm
or CA125 30
Surgery general
gynaecologist   
RMI 25–250
Surgery required cancer
unit
Figure 1. Flow diagram of patient selection and randomisation for the RCT: RCOG/RMI vs SRMP.
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of women suffering surgical complications and the number of
delayed diagnoses of ovarian cancer, which was defined as a diagnosis
of an ovarian malignancy beyond the first visit but o1 year.
Statistical analysis
Sample size. A sample size of 148 patients was required to detect a
difference of 31% in the intervention rate at the 5% significance
level (two-sided) with 90% power, assuming that the intervention
rate in RMI/RCOG arm is 62% and that there is 20% dropout.
Statistical analyses. Patients were analysed according to the
groups to which they were randomised. The analysis of surgery
offered included all randomised patients. The final analysis of those
who had surgery included those who had surgery within 1 year or
completed 1 year of follow-up ultrasound scans.
The results were described using relative risks (RR) and the risk
differences with 95% CIs. The w2-test was used to formally
compare the intervention rates in the two trial arms. Fisher’s exact
test was used to compare complication rates and staging surgical
procedures done by a gynaecological oncologist.
Statistical analysis was performed using Stata 14 software (Stata
Corp).
Any adverse events were assessed for severity according to the
University College Hospital Trial Coordinating Centre’s criteria
and recorded in the database.
This study was entered in the registry of randomised trials
(ISRCTN89034131).
RESULTS
From April 2011 to June 2014, 951 postmenopausal women were
diagnosed with adnexal tumours in our centre. The CONSORT
flow diagram is seen in Figure 2. After excluding women with
simple unilateral, unilocular cysts o2 cm (n¼ 269), those outside
the defined age range (n¼ 121) and those with pain (87), there
were 474 women remaining. A further 274 were not eligible. About
200 women fulfilled the final inclusion criteria, 148 of whom
agreed to take part in the study and 52 of whom declined. About 73
women were randomised to RMI/RCOG and 75 to SRMP. Their
ages ranged from 49 to 80 with a mean age of 63. The two groups
were balanced in their demographic characteristics (Table 1).
Protocol assessment. About 44 (60.3%) of the RMI/RCOG
patients were assessed as either indeterminate or malignant
compared with 5 (6.7%) of the SRMP patients (Tables 2 and 3).
This study shows that the rate of malignant or indeterminate
diagnoses is higher for RMI/RCOG patients (Po0.001, w2-test).
The difference in these proportions is 53.6% (95% CI: 41.0–66.2%)
and the RR is 9.0 (95% CI: 3.8–21.5). While there was one tumour
assessed as malignant in each arm. The main difference was in the
intermediate groups with 43 in the RMI/RCOG arm and 4 in the
SRMP arm (Table 2).
Initial management. Out of the 44 women triaged for surgery in
the RMI/RCOG arm, 18 (40.9%) had surgery as planned, 7 (15.9%)
were not fit for surgery and 19 (43.2%) declined the operation for
various reasons. All women who declined surgery were in the
intermediate-risk group. All five women assigned to surgery in the
SRMP arm had operations.
Thus, following the initial assessment, 18 out of 73 (24.7%)
RMI/RCOG patients had surgery compared to 5 out of 75 (6.7%)
SRMP. There is strong evidence that the rate of surgery is higher
for RMI/RCOG patients (P¼ 0.003, w2-test). The difference in
these proportions is 18.0% (95% CI: 6.6–29.4%) and the RR is 3.70
(95% CI: 1.45–9.44).
Primary analysis: management at 12 months (‘ITT’ analysis).
The surgical status of 136 patients is known at 12 months. There
were two women who had surgery during follow-up. One woman
was offered surgery because of her personal recent diagnosis of
breast cancer and the other was diagnosed with an early
endometrial cancer. They were both in the SRMP arm, both
operated on by gynaecological oncologists and both adnexal lesions
were benign on histological examination. Neither woman had yet
had her first follow-up ultrasound scan. After completion of
follow-up, 18 out of 68 (26.5%) RMI/RCOG patients had surgery
compared to 7 out of 68 (10.3%) in the SRMP arm (Tables 2 and
3). There is strong evidence that the rate of surgery is higher for
RMI/RCOG patients (P¼ 0.015, w2-test). The difference in these
proportions is 16.2% (95% CI: 3.4–28.9%) so, therefore, for every
100 patients we expect an additional 16 patients to have surgery
after assessment by RMI/RCOG compared to assessment via
Simple Rules. The RR is 2.57 (95% CI: 1.15–5.76) ,so there is a 2.6
times higher chance of surgery following assessment by RMI/
RCOG compared to assessment via Simple Rules.
Postmenopausal women with an adnexal tumour N=951
Eligible patients N=474 after excluding N=477 due to cyst type, age, pain
Eligible patients randomised after giving consent N  = 148
RMI/RCOG N = 73 (49%)
Benign
N = 29 (39.7%)
Conservative
N  = 29 (100%)
Conservative
N  = 23
(79.3%)
Lost to
follow-up
N=2
Missing
data N=4
Malignant/ Intermediate
N = 44 (60.3%) 
Conservative
N = 26 (59.1%) 
Conservative
N = 23
(88.5%)
Lost to
follow-up
N=3
Surgery
N = 18 (40.9%)
SRMP N = 75 (51%)
Benign
N = 70 (93.3%)
Conservative
N = 70 (100%)
Conservative
N = 61
(87.1%)
Surgery
N = 2
(2.9%)
Lost to
follow-up
N=5
Deceased
N=2
Malignant/ Intermediate
N = 5 (6.7%)
Surgery
N = 5 (100%)
Excluded N=274
Declined N=52
Figure 2. CONSORT diagram.
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Secondary outcomes. Two women, one in each arm were
identified as having high-risk tumours and they both had staging
procedures (one laparoscopy and one laparotomy) by gynaecolo-
gical oncologists. In both cases the histological diagnosis was a
borderline tumour.
There were five women with low or intermediate risk tumours
who were referred to the tertiary oncology centre. Two women
categorised as having benign tumours had secondary staging
surgery in the tertiary cancer unit as one of them had a concomitant
breast and another endometrial cancer. Three women in the
intermediate-risk group also had primary staging surgery. One had
a large borderline tumour and it was anticipated that the surgery will
be technically difficult, another was known to suffer from bowel
cancer and the third woman with a borderline cyst was referred
directly to the cancer centre by her GP and had surgery there.
There was little difference in the proportions of women referred
to the tertiary oncology unit between the two groups of women
(3 out of 73 (4.1%) in RMI/RCOG and 4 out of 75 (5.3%) in
SRMP). The risk difference was 1.2% (95% CI:  0.6 to 2.9%). The
RR was 1.28 (95% CI: 0.3–5.54; P¼ 0.74).
Surgical complications occurred in 4 out of 73 (5.5%) women in
the RMI/RCOG arm and 2 out of 75 (2.7%) in the SRMP arm. This
was not statistically significant when either a total number of
women in each arm or a total number of women who underwent
surgical procedures in each arm were used as denominators. There
were no delayed diagnoses of ovarian cancer detected up to 12
months of follow-up by the assigned protocol assessment.
Histological diagnoses are listed in Table 4. There were 25
women who had their surgery within the first year following the
initial assessments. Six women with malignant tumours on
histology (two invasive tumours and four borderline tumours)
were identified as high or intermediate risks by either diagnostic
model. Five of them had surgery within 2 months of the initial
visit, while the remaining woman with a cardiac condition had her
surgery delayed for 8 months in order to optimise her general
health. There was one invasive malignancy and one borderline
tumour in the RMI/RCOG arm and one invasive malignancy, and
three borderline tumours in the SRMP arm.
About 23 out of 26 (88.5%) women, who were assessed as
needing surgery but were either deemed surgically unfit (7) or
declined operations (19), completed their 12 months follow-up
without any morphological changes that altered their category
assessment. Two of them went on to have surgery after 1 year.
They were found to have benign lesions on histological examina-
tion. Of the remaining three women who did not attend for follow-
up visits, one had her 12-month scan elsewhere. The examination
did not reveal any significant changes in the appearance of her
adnexal lesion. We had no information about the remaining two
women who were lost to follow-up. There were two women in the
SRMP arm who had tumours classified as benign, who died before
completing their 12 months of follow-up. One patient was
diagnosed with small-cell lung cancer and the other was diagnosed
with acute lymphoblastic leukaemia.
DISCUSSION
Main findings. Our study has shown that the intervention rates
were significantly higher in the RMI/RCOG protocol arm
compared to women the SRMP arm. This occurred without an
increase in delayed diagnoses of ovarian cancer during the 12
months of follow-up. The proportion of women classified as
having high-risk tumours was the same in both arms of the study
and the main difference between the protocols was in the
proportions of women who were classified as having intermedi-
ate-risk lesions.
The significant difference in number of lesions classified as
intermediate risk led to a significant difference in the actual
intervention rates as well. This indicates that a large proportion of
postmenopausal women with adnexal tumours in the United
Kingdom may be undergoing unnecessary operations that could be
avoided. Women classified as having tumours of intermediate risk
are often anxious about the possibility of having an aggressive
invasive tumour, which may have adverse effect of their
psychological health and social well-being. The UKCTOCS trial
found significantly higher anxiety levels in women with abnormal
results on ultrasound screening (Barrett et al, 2014). The cost of
surgery is high and avoiding unnecessary operations may result in
significant savings to health providers and to society as a whole.
A relatively large number of women with intermediate-risk
lesions in the RMI/RCOG arm of the study declined surgery. This
could be partially explained by the delay in proving women with
the risk assessment until the CA125 results were available. The
majority of women who required intervention in the RMI group
had relatively simple cysts and they were told that their RMI
Table 2. Patient assessment, follow-up and outcomes N¼148
RMI/RCOG (n¼73)
n (%)
SRMP (n¼75)
n (%)
Protocol assessment classification
Protocol¼Benign 29 (39.7%) 70 (93.3%)
Protocol¼ Indeterminate 43 (58.9%) 4 (5.3%)
Protocol¼Malignant 1 (1.4%) 1 (1.3%)
Protocol¼ Surgery 44 (60.3%) 5 (6.7%)
Study completion
Completed 4 months 72 (98.6%) 75 (100%)
Completed 8 months 69 (94.5%) 70 (93.3%)
Completed 12 months of study 68 (93.2%) 68 (90.7%)
Surgical management
Surgery p1 year 18 (24.7%) 7 (9.3%)
Declined/unfit for surgery 26 (35.6%) 0
Abbreviations: RCOG¼Royal College of Obstetricians and Gynaecologists guideline;
RMI¼Risk of Malignancy Index; SRMP¼ Simple Rules Management Protocol.
Table 1. Baseline patient characteristics by trial arm in the
RMI/RCOG and the SRMP arms (N¼148)
RMI/RCOG
(n¼73) SRMP (n¼75)
Age (years)
Mean 62.7 (7.6) 63.8 (8.1)
Range 49–80 50–80
Parity n (%)
0 22 (30%) 27 (36%)
1 11 (15%) 8 (11%)
2 20 (27%) 19 (25%)
X3 20 (27%) 21 (28%)
Time since menopause (years)
Mean 12.5 (8.8) 13.7 (9.3)
Range 0–37 1–33
Current HRT use n (%)
Yes 10 (14%) 11 (15%)
Past HRT use n(%)
Yes 12 (16%) 19 (25%)
No 49 (67%) 45 (60%)
NA 10 (14%) 11 (15%)
UK 2 (3%) 0
Abbreviations: HRT¼hormone replacement therapy; NA¼ not applicable (patients
currently using HRT); RCOG¼Royal College of Obstetricians and Gynaecologists guideline;
RMI¼Risk of Malignancy Index; SRMP¼ Simple Rules Management Protocol; UK¼
Unknown. Values are either mean (s.d.) for continuous variables or n (%) for categorical
variables.
Simple rules vs RMI in postmenopausal adnexal tumours BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2017.17 5
ultrasound score was low. However, when the result of serum
CA125 became available their cysts were classified as intermediate
risk. This could explain the higher non-compliance in this arm of
the study. This trend was absent in the SRMP arm as the women
assigned to this protocol were provided with instant information
on the likely tumour nature and advice and management. In
addition, women who have a priori preference for surgery are likely
to have declined to participate in this study and to have directly
requested surgical intervention. During follow-up of the inter-
mediate-risk women who declined surgery, none of them had their
cysts re-classified as high risk. This was the case for all women who
had expectant care with follow-up ultrasound scans over 1 year.
The cysts that were indeterminate according to the SRMP
analysis are the cysts where the rules were not applicable. This was
only 5% (4 out of 75) of the women in that arm of the study. A
recent meta-analysis showed that the proportion of women in
whom the Simple Rules were not applicable varied between 10.7
and 23.9% (Nunes et al, 2014). However, all studies included in the
meta-analysis were carried out on women who were scheduled to
have surgical treatment. Our population was different as we only
included asymptomatic women who attended outpatient clinics.
They were more likely to be diagnosed with simple benign-looking
cysts. This difference in patient selection could explain the higher
relative proportion of cysts classified as benign, compared to other
studies.
A significant proportion of women was deemed unfit for
surgery, which confirms that the risks of operating on older
women are increased and reiterates the need to develop effective
strategies to reduce the number of avoidable procedures in this age
group.
We decided to follow women up for 12 months, as there is
evidence from the literature that this is a sufficient time span to
detect changes in the morphology and size of the adnexal tumours,
which could indicate their malignant nature (Horiuchi et al, 2003;
Shih and Kurman, 2004; Suh-Burgmann et al, 2014). A study by
Horiuchi et al (2003) showed that the majority of women who
developed ovarian cancer in previously detected cysts had either
borderline tumours or well-differentiated early stage invasive
lesions. These results support a conservative approach to the care
of women with benign-looking adnexal lesions on initial
Table 3. Results according to risk category N¼148
RMI/RCOG (N¼73) n (%) SRMP (N¼75) n (%)
Low risk
Assigned to category 29 (39.7%) 70 (93.3%)
Primary non-staging surgery, benign outcome 0 0
Primary non-staging surgery, malignant outcome 0 0
Primary staging surgery, benign outcome 0 0
Primary staging surgery, malignant outcome 0 0
Accepted follow-up 29 (100%) 70 (100%)
Completed follow-up 23 (79.3%) 61 (87.1%)
Lost to follow-up/missing data/deceased 6 (20.7%) 7 (10.0%)
Secondary non-staging surgery, benign outcome 0 0
Secondary non-staging surgery, malignant outcome 0 0
Secondary staging surgery, benign outcome 0 2 (2.7%)a
Secondary staging surgery, malignant outcome 0 0
Intermediate risk
Assigned to category 43 (58.9%) 4 (5.3%)
Primary non-staging surgery, benign outcome 16 (37.2%) 1(25.0%)
Primary non-staging surgery, malignant outcome 0 1 (25.0%)b
Primary staging surgery, benign outcome 0 0
Primary staging surgery, malignant outcome 1 (2.3%)c 2 (50.0%)d
Requested ultrasound scan follow-up 19 (44.2%) 0
Not fit for surgery, ultrasound scan follow-up 7 (16.3%) 0
Surgery during follow-up 0 0
High risk
Assigned to category 1 (1.4%) 1 (1.3%)
Primary non-staging surgery, benign outcome 0 0
Primary non-staging surgery, malignant outcome 0 0
Primary staging surgery, benign outcome 0 0
Primary staging surgery, malignant outcome 1 (100%)e 1 (100%)e
Referred tertiary oncology unit 1 1
Requested ultrasound scan follow-up 0 0
Not fit for surgery, follow-up 0 0
Surgery during follow-up 0 0
Total patients
Surgery 18 7
Primary surgery 18 5
Primary surgery, benign outcome 16 1
Primary surgery, malignant outcome 2 4
Secondary surgery 0 2
Secondary surgery, benign outcome 0 2
Secondary surgery, malignant outcome 0 0
Abbreviations: RCOG¼Royal College of Obstetricians and Gynaecologists guideline; RMI¼Risk of Malignancy Index; SRMP¼ Simple Rules Management Protocol.
aReferred to oncology: one diagnosed with breast cancer, one diagnosed with endometrial cancer.
bPapillary thyroid cancer probably having arisen in a dermoid.
cMetastatic bowel cancer.
dTwo borderline ovarian tumours.
eBorderline ovarian tumour.
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ultrasound scans. In contrast women diagnosed with aggressive
disseminated invasive ovarian cancers typically had no detectable
precursor lesions on previous imaging. Similar findings were also
reported by Shih and Kurman (2004) in 2004. Suh-Burgmann
et al (2014) found that growth of the tumours was clear
by 7 months for all women subsequently diagnosed with a
borderline or epithelial tumour when women over age 50 with
complex adnexal tumours had ultrasound follow-up of their
tumours.
Strengths and limitations. The main strength of our study is that
it is the first randomised controlled trial looking at the use of the
RMI/RCOG protocol, which is widely used in clinical practice in
the United Kingdom and compared it to a novel alternative
management strategy. The SR diagnostic model, which underpins
our novel management protocol, had been extensively studied in
the past and all the results showed that it was suitable for the use in
clinical practice. The study was carefully planned and the power
calculation was based on the results of a prospective audit, which
had been carried out prior to starting the trial. Although it was not
possible to blind women and all clinicians to the patient allocation,
the pathologist and the surgeons were not aware which protocol
was used in individual patients.
The main limitation was that this was a single centre study,
which limits the applicability of the results in other units. Further
prospective studies in different diagnostic units are needed to
ensure that our findings are widely applicable.
We did not blind the recruiting physician once the woman
was assigned to an arm of the trial that could have influenced
their approach to the conduct of ultrasound scan. We also did not
blind the patients to their trial allocation, which could have
influenced their compliance with the protocol as they were less
likely to follow a new rather than a traditional well-tested
approach. Our data showed, however, that the compliance was
less with the standard compared to the novel management
protocol. Simple Rules require higher ultrasound skill than RMI,
which may affect the performance of the test in unit with lower
ultrasound skills.
CONCLUSION
In conclusion our study has shown that the introduction of ‘simple
rules’ into routine clinical practice could result in a significant
reduction in the number of surgical procedures offered to
postmenopausal women with incidental diagnoses of adnexal cysts
on imaging. Further larger studies, including units with different
levels of ultrasound expertise, are required to explore or confirm
these findings.
Implications for clinicians or policymakers. This study shows
that relatively minor changes in the management protocols for
women with adnexal tumours could result in significant differences
in the number of surgical interventions. The diagnosis of suspected
ovarian cancer often causes anxiety to women and their carers, and
they are typically urgently referred to gynaecological oncologists in
cancer centres. Algorithms based on models with low specificity
would therefore cause significant pressure on sub-specialist services
and further increase the cost of care. Further multicentre studies
are required to confirm our findings and would facilitate
development of more effective and rational care for postmeno-
pausal women with adnexal tumours.
ACKNOWLEDGEMENTS
I would like to acknowledge Mr Paul Bassett as the statistician who
did the sample size calculation and generated the randomisation
list. NN, XF, GD were supported by the research fund provided by
the Gynaecology Ultrasound Centre Limited, London, UK. GA
received a proportion of funding from the UK Department of
Health’s NIHR Biomedical Research Centre’s funding scheme. The
first author had full access to all the data in the study and had final
responsibility for the decision to submit for publication. Trial
registration number: ISRCTN89034131. http://www.controlled-
trials.com/ISRCTN89034131/.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
REFERENCES
Ansaloni L, Catena F, Chattat R, Fortuna D, Franceschi C, Mascitti P, Melotti RM
(2010) Risk factors and incidence of postoperative delirium in elderly
patients after elective and emergency surgery. Br J Surg 97: 273–280.
Barrett J, Jenkins V, Farewell V, Menon U, Jacobs I, Kilkerr J, Ryan A,
Langridge C, Fallowfield LUKCTOCS trialists (2014) Psychological
morbidity associated with ovarian cancer screening: results from more
than 23 000 women in the randomised trial of ovarian cancer screening
(UKCTOCS). BJOG 121(9): 1071–1079.
Ben-Ami I, Vaknin Z, Schneider D, Halperin R (2006) Perioperative
morbidity and mortality of gynecological oncologic surgery in elderly
women. Int J Gynecol Cancer 16(1): 452–457.
Conway C, Zalud I, Dilena M, Maulik D, Schulman H, Haley J, Simonelli K
(1998) Simple cyst in the postmenopausal patient: detection and
management. J Ultrasound Med 17(6): 369–372.
Geomini P, Kruitwagen R, Bremer GL, Cnossen J, Mol BW (2009) The
accuracy of risk scores in predicting ovarian malignancy: a systematic
review. Obstet Gynecol 113(2 Pt 1): 384–394.
Horiuchi A, Itoh K, Shimizu M, Nakai I, Yamazaki T, Kimura K, Suzuki A,
Shiozawa I, Ueda N, Konishi I (2003) Toward understanding the natural
history of ovarian carcinoma development: a clinicopathological approach.
Gynecol Oncol 88: 309–317.
Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG (1990) A risk
of malignancy index incorporating CA 125, ultrasound and menopausal
Table 4. Histological diagnoses N¼26
RMI/RCOG
(N¼73) n (%)
SRMP (N¼75)
n (%)
Benign
Cystadenoma/cystadenofibroma
(two with a fibroma and one with a
Brenner tumour)
8 3
Endometriomas 3
Fibroma 2
Fibrothecoma 1
Benign stromal tumour and
simple cyst
1
Inclusion cyst with hydrosalpinx 1
Total benign (n¼ 19) 16 3
Borderline
Borderline serous 1 2
Borderline mucinous (with a
contralateral benign serous
cystadenoma)
1
Total borderline (n¼ 4) 1 3
Invasive malignancies
Papillary thyroid type carcinoma
within a dermoid
1
Metastatic colorectal cancer 1
Total invasive malignancies (n¼ 2) 1 1
Total patients who had surgery 18 7
Abbreviations: RCOG¼Royal College of Obstetricians and Gynaecologists guideline;
RMI¼Risk of Malignancy Index; SRMP¼Simple Rules Management Protocol.
Simple rules vs RMI in postmenopausal adnexal tumours BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2017.17 7
status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet
Gynecol 97(10): 922–929.
Kaijser J, Sayasneh A, Van Hoorde K, Ghaem-Maghami S, Bourne T,
Timmerman D, Van Calster B (2014) Presurgical diagnosis of adnexal
tumours using mathematical models and scoring systems: a systematic
review and meta-analysis. Hum Reprod Update 20(3): 449–462.
Krause AK, Muntz HG, McGonigle KF (2016) Robotic-assisted gynecologic
surgery and perioperative morbidity in elderly women. J Minim Invasive
Gynecol 23(6): 949–953.
Neufeld KJ, Leoutsakos JM, Sieber FE, Wanamaker BL, Gibson Chambers JJ, Rao V,
Schretlen DJ, Needham DM (2013) Outcomes of early delirium diagnosis
after general anesthesia in the elderly. Anesth Analg 117: 471–478.
Nunes N, Foo X, Widschwendter M, Jurkovic D (2012) A randomised
controlled trial comparing surgical intervention rates
between two protocols for the management of asymptomatic
adnexal tumours in postmenopausal women. BMJ Open 2(6):
e002248.
Nunes N, Ambler G, Foo X, Naftalin J, Widschwendter M, Jurkovic D (2014)
Use of the IOTA simple rules for the diagnosis of ovarian cancer: a meta-
analysis. Ultrasound Obstet Gynecol 44(5): 503–514.
RCOG (2003) Ovarian Cysts in Postmenopausal Women (Green-top Guideline
34), London, UK.
RCOG (2011) Ovarian Masses in Premenopausal Women, Management of
Suspected (Green-top Guideline No. 62), London, UK.
Shih IeM, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model
based on morphological and molecular genetic analysis. Am J Pathol 164:
1511–1515.
Suh-Burgmann E, Hung YY, Kinney W (2014) Outcomes from ultrasound
follow-up of small complex adnexal masses in women over 50. Am J
Obstet Gynecol 211: 623.
Sztark F, Le Goff M, Andre´ D, Ritchie K, Dartigues JF, Helmer C (2013)
Exposure to general anaesthesia could increase the risk of dementia in
elderly: 18AP1-4. Eur J Anaesthesiol 30: 245–245.
Timmerman D, Testa AC, Bourne T, Ameye L, Jurkovic D, Van Holsbeke C,
Paladini D, Van Calster B, Vergote I, Van Huffel S, Valentin L (2008)
Simple ultrasound-based rules for the diagnosis of ovarian cancer.
Ultrasound Obstet Gynecol 31(6): 681–690.
Vernooij F, Heintz P, Witteveen E, van der Graaf Y (2007) The outcomes of
ovarian cancer treatment are better when provided by gynecologic
oncologists and in specialized hospitals: a systematic review. Gynecol
Oncol 105(3): 801–812.
This work is published under the standard license to publish agree-
ment. After 12 months the work will become freely available and
the license terms will switch to a Creative Commons Attribution-
NonCommercial-Share Alike 4.0 Unported License.
BRITISH JOURNAL OF CANCER Simple rules vs RMI in postmenopausal adnexal tumours
8 www.bjcancer.com |DOI:10.1038/bjc.2017.17
